Article info

Download PDFPDF
Engineered IFN-α and anti-PDL1 containing compounds to target the liver and restore antiviral protection for HBV cure

Authors

  1. Correspondence to Dr Paola Fisicaro, Unit of Infectious Diseases and Hepatology, Azienda Ospedaliero-Universitaria di Parma, Parma, 43126, Italy; pfisicaro{at}ao.pr.it
View Full Text

Citation

Fisicaro P
Engineered IFN-α and anti-PDL1 containing compounds to target the liver and restore antiviral protection for HBV cure

Publication history

  • Received November 28, 2022
  • Accepted December 5, 2022
  • First published December 13, 2022.
Online issue publication 
October 18, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.